Septal Defects

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2011-06-30
Clinical Trial Update: InterSEPT: In-Tunnel SeptRx European PFO Trial [NA]
An update on the InterSEPT European PFO trial by SeptRx, Inc. indicates the trial status is currently unknown.